Neuroeconomics of Drug Addiction

毒瘾的神经经济学

基本信息

  • 批准号:
    7856466
  • 负责人:
  • 金额:
    $ 65.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The nascent interdisciplinary field of Neuroeconomics harnesses the computational rigor of economics and the technological advances of modern biology to advance discovery in the decision sciences. Since pathologies of decision making are endemic to addiction-they serve a causal role in its development, they exacerbate the biological and social consequences of the disorder, and they impair remediation and treatment ~ the National Institutes of Health has recognized Neuroeconomics as fundamental to solving this important societal problem. Here we propose a National Institute of Drug Abuse (NIDA) P30 Core Center uniting two areas of institutional strength at Duke, Neuroeconomics/Cognitive Neuroscience and Interdisciplinary Addiction Research, to support hiring two new faculty, each in partnership with the Duke Institute for Brain Sciences (DIBS) and an academic department: Duke is an internationally recognized leader in both of these fields, yet their collective strengths have not yet been brought to bear on core problems of decision making in addiction. There are several areas of existing institutional strength in these areas that include the Center for Neuroeconomic Studies (CNS), the Center for Cognitive Neuroscience (CCN), the NIDA-supported Translational Prevention Research Center (TPRC), the Duke Center for Nicotine and Smoking Cessation Research (CNSCR), The Fuqua School of Business, and the strong behavioral neuroscience groups within the Departments of Neurobiology, Psychiatry, and Psychology and Neuroscience. Despite these strengths, fundamental gaps remain. The proposed Core Center will fill important gaps in the Duke decision-making research community, will bring important and cutting-edge research competencies, and will strengthen Duke's position as one of the leading institutions in this important research area. It will bring new teaching capabilities to the undergraduate neuroscience major and to graduate training more broadly. Finally, it will provide an important new link for DIBS to socially relevant applications for neuroscience, consistent with Duke's strategic goal of "Knowledge in the Sen/ice of Society". A NIDA P30 Core Center will give Duke the leverage to immediately fill these gaps and catalyze integration of these disparate groups by hiring two new faculties that each brings new expertise bridging current Neuroeconomics and Addiction research at Duke.
描述(由申请人提供):神经经济学的新兴跨学科领域利用经济学的计算严谨性和现代生物学的技术进步来推进决策科学的发现。由于决策的病理是成瘾的地方病,它们在成瘾的发展中起着因果作用,它们加剧了疾病的生物和社会后果,并且它们损害了补救和治疗-美国国立卫生研究院已经认识到神经经济学是解决这一重要社会问题的基础。在这里,我们建议建立一个国家药物滥用研究所(NIDA)P30核心中心,将杜克的两个机构优势领域,神经经济学/认知神经科学和跨学科成瘾研究结合起来,以支持聘请两名新教师,每名教师都与杜克脑科学研究所(DIBS)和一个学术部门合作:杜克在这两个领域都是国际公认的领导者,但他们的集体力量还没有被带到成瘾决策的核心问题上。在这些领域有几个现有的机构力量领域,包括神经经济学研究中心(CNS),认知神经科学中心(CCN),NIDA支持的转化预防研究中心(TPRC),杜克尼古丁和戒烟研究中心(CNSCR),Fuqua商学院以及神经生物学,精神病学,心理学和神经科学尽管有这些优势,但仍然存在根本性的差距。拟议中的核心中心将填补杜克决策研究界的重要空白,将带来重要和前沿的研究能力,并将加强杜克作为这一重要研究领域的领先机构之一的地位。它将为本科神经科学专业和更广泛的研究生培训带来新的教学能力。最后,它将为DIBS提供一个重要的新链接,以社会相关的神经科学应用,符合杜克的战略目标“知识在社会服务”。NIDA P30核心中心将使杜克能够立即填补这些空白,并通过聘请两名新教师来促进这些不同群体的整合,这两名教师都带来了新的专业知识,将杜克目前的神经经济学和成瘾研究联系起来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID FITZPATRICK其他文献

DAVID FITZPATRICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID FITZPATRICK', 18)}}的其他基金

CRCNS: US-German Res Prop: The Role of Spontaneous Activity in Cortical Development
CRCNS:美国-德国 Res Prop:自发活动在皮质发育中的作用
  • 批准号:
    9335859
  • 财政年份:
    2015
  • 资助金额:
    $ 65.96万
  • 项目类别:
New Molecular Tools to Characterize Cortical Circuit Function in Non-Murine Mamma
表征非鼠妈妈皮层回路功能的新分子工具
  • 批准号:
    8489440
  • 财政年份:
    2013
  • 资助金额:
    $ 65.96万
  • 项目类别:
New Molecular Tools to Characterize Cortical Circuit Function in Non-Murine Mamma
表征非鼠妈妈皮层回路功能的新分子工具
  • 批准号:
    8616378
  • 财政年份:
    2013
  • 资助金额:
    $ 65.96万
  • 项目类别:
CORE--FUNCTIONAL ANALYSIS /EXPRESSION
核心--功能分析/表达
  • 批准号:
    7666243
  • 财政年份:
    2008
  • 资助金额:
    $ 65.96万
  • 项目类别:
CORE--FUNCTIONAL ANALYSIS /EXPRESSION
核心--功能分析/表达
  • 批准号:
    7479137
  • 财政年份:
    2007
  • 资助金额:
    $ 65.96万
  • 项目类别:
CORE--FUNCTIONAL ANALYSIS /EXPRESSION
核心--功能分析/表达
  • 批准号:
    6845950
  • 财政年份:
    2004
  • 资助金额:
    $ 65.96万
  • 项目类别:
MRM FOR MAPPING FUNCTIONAL ARCHITECTURE OF VISUAL CORTEX IN FERRETS
用于绘制雪貂视觉皮层功能结构的 MRM
  • 批准号:
    6122304
  • 财政年份:
    1999
  • 资助金额:
    $ 65.96万
  • 项目类别:
MRM FOR MAPPING FUNCTIONAL ARCHITECTURE OF VISUAL CORTEX IN FERRETS
用于绘制雪貂视觉皮层功能结构的 MRM
  • 批准号:
    6282339
  • 财政年份:
    1998
  • 资助金额:
    $ 65.96万
  • 项目类别:
MRM FOR MAPPING FUNCTIONAL ARCHITECTURE OF VISUAL CORTEX IN FERRETS
用于绘制雪貂视觉皮层功能结构的 MRM
  • 批准号:
    6253332
  • 财政年份:
    1997
  • 资助金额:
    $ 65.96万
  • 项目类别:
Local Circuits & Direction Selectivity in Visual Cortex
本地电路
  • 批准号:
    6438923
  • 财政年份:
    1996
  • 资助金额:
    $ 65.96万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 65.96万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了